Expertise in

conditions

Claus Belka

Robert Koch Str. 1,

Landshut, BY, DE

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

Robert Koch Str. 1,

Landshut, BY, DE

Overview

Claus Belka practices practicing medicine in Landshut, Germany.

Mr. Belka is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Glioma, Gliomatosis Cerebri, Prostatectomy, and Mastectomy.

He is actively involved in clinical research, co-authoring 545 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Robert Koch Str. 1, Landshut, BY 84034, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head and Neck Squamous Cell Carcinomas: A Phase I Study to Reduce Late Toxicity

Enrollment Status: Recruiting

Publish Date: September 22, 2025

Intervention Type: Radiation

Study Phase: Not Applicable

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma.

Enrollment Status: Active_not_recruiting

Publish Date: September 19, 2024

Intervention Type: Radiation, Drug

Study Drugs: Durvalumab, 5-Fluorouracil, Mitomycin C

Study Phase: Phase 2

A Phase III Randomized Study of Preoperative Radiotherapy Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcoma (RPS)

Enrollment Status: Completed

Publish Date: April 24, 2023

Intervention Type: Procedure, Radiation

Study Phase: Not Applicable

Observational Study on Biomarkers in Head and Neck Cancer

Enrollment Status: Completed

Publish Date: August 03, 2022

Intervention Type: Biological

SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy

Enrollment Status: Terminated

Publish Date: April 14, 2022

Intervention Type: Radiation, Drug

Study Drug: Metformin

Study Phase: Phase 2

Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation

Enrollment Status: Completed

Publish Date: July 22, 2020

Intervention Type: Radiation

Study Phase: Not Applicable

View 5 Less Clinical Trials

545 Total Publications

Early local immune activation following intra-operative radiotherapy in human breast tissue.

Journal: Oncoimmunology

Published: April 07, 2026

View All 545 Publications

Frequently Asked Questions about Claus Belka

Is Claus Belka a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Claus Belka is classified as an Elite expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Claus Belka participate in research or clinical trials?

Yes. Claus Belka has published 545 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Claus Belka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Belka's expertise for a condition

ConditionClose